BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $256,000 | -0.4% | 1,625 | -7.5% | 0.01% | +8.3% |
Q3 2018 | $257,000 | +1.2% | 1,757 | +8.7% | 0.01% | 0.0% |
Q2 2018 | $254,000 | +10.9% | 1,616 | +20.4% | 0.01% | +9.1% |
Q1 2018 | $229,000 | -23.9% | 1,342 | -20.6% | 0.01% | +10.0% |
Q4 2017 | $301,000 | +30.9% | 1,690 | +1.0% | 0.01% | +25.0% |
Q3 2017 | $230,000 | – | 1,673 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |